📅 Published
March 16, 2026
(Monday)
March 16, 2026
(Monday)
Titan Biotech (BSE: 524717) turned ₹8 into ₹400 — a stunning 50x multibagger return! Learn the 3 key factors that drove this incredible growth through value investing.
Key Highlights:
- Consistent Revenue Growth — From ₹60 Cr to ₹300+ Cr
- Expanding Profit Margins — Operational efficiency at its best
- Strong Management — Clear vision and strategic execution
📈 Want to find the next multibagger? Visit manishgoelstocks.com
Multibagger Securities Research & Advisory Pvt. Ltd. | SEBI Registered Investment Advisor: INA100007736
Disclaimer: This content is for educational purposes only. Stock markets are subject to risks. Past performance does not guarantee future returns.
📢 Join Our Telegram Channel
Get daily value investing lessons, stock analysis & Titan Biotech updates — delivered straight to your phone!
✈️ Join @longtermequityy on Telegram
🔔 Free • No spam • Value investing insights daily
Titan Biotech: From ₹8 to ₹400 — The 50x Multibagger Story | Value Investing #Shorts